BPH术后球膜部狭窄的尿道成形术:系统综述与荟萃分析
该系统综述与荟萃分析评估了BPH内镜手术后球膜部尿道狭窄行尿道成形术的通畅率、尿失禁和勃起功能。纳入11项研究669例患者,9项研究417例进入主分析,合并通畅率90%(95%CI 85-93%),尿失禁率5%(95%CI 3-10%),勃起功能数据不足以合并分析。
要点
- BPH术后球膜部狭窄尿道成形术合并通畅率90%(95%CI 85-93%),尿失禁率5%(95%CI 3-10%)。
- 通畅率定义异质,多指免于再干预而非解剖学确认通畅。
- 证据异质且非比较性,无法给出技术特异性推荐。
核心结论
- BPH术后球膜部狭窄尿道成形术在经验丰富的中心可获得高通畅率(定义异质,多指免于再干预)和低新发尿失禁率。
研究设计与样本
- 按PRISMA 2020指南进行的预注册系统综述(PROSPERO CRD420261374244),检索PubMed和EMBASE观察性研究。
- 纳入报告≥10例BPH术后球膜部、膜部或近端球部狭窄尿道成形术结局的观察性研究。
- 共纳入11项研究669例患者,其中9项研究417例患者进入主要定量分析。
- 所有研究为回顾性或前瞻性观察性队列,偏倚风险为中至严重。
主要发现
- 总体合并通畅率90%(95%CI 85-93%),异质性中等(Q=11.22)。
- 按技术亚组:腹侧覆盖颊黏膜移植(BMG)通畅率87%(95%CI 76-93%,4项研究)。
- 吻合性尿道成形术通畅率94%(95%CI 87-97%,3项研究)。
- 背侧覆盖BMG通畅率91%(95%CI 83-95%,1项研究)。
- 合并尿失禁率5%(95%CI 3-10%),异质性中等(Q=11.38)。
关键数值与推荐
- 通畅率定义在各研究间异质,主要定义为免于再干预而非客观确认的解剖学通畅。
- 尿失禁和控尿定义在各研究间异质。
临床怎么用
- 在经验丰富的中心,尿道成形术可用于BPH术后球膜部狭窄,通畅率较高且新发尿失禁率低。
- 因证据异质且非比较性,无法给出技术特异性推荐,需个体化选择术式。
局限性
- 所有研究为观察性队列,偏倚风险中至严重。
- 通畅率和控尿定义异质,通畅率多指免于再干预。
- 证据非比较性,无法进行技术间比较。
- 勃起功能数据不足,无法合并分析。
- 需要前瞻性、标准化研究以优化患者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically evaluate surgical outcomes of urethroplasty for bulbomembranous urethral strictures developing after endoscopic surgery for benign prostatic hyperplasia (BPH), focusing on patency, urinary continence, and erectile function. PATIENTS AND METHODS: A pre-registered systematic review (International Prospective Register of Systematic Reviews [PROSPERO] identifier: CRD420261374244) was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed and the Excerpta Medica database (EMBASE) were searched for observational studies reporting urethroplasty outcomes in ≥10 patients with post-BPH bulbomembranous, membranous, or proximal bulbar strictures. Risk of bias was assessed using the Risk Of Bias In Non-randomised Studies of Interventions (ROBINS-I). Random-effects meta-analysis with logit back-transformation and Hartung-Knapp-Sidik-Jonkman correction pooled proportions of patency and urinary incontinence (UI), stratified by technique. RESULTS: A total of 11 studies comprising 669 patients were identified, of which nine (417 patients) were included in the primary quantitative analysis. All studies were retrospective or prospective observational cohorts with moderate-to-serious risk of bias. Definitions of patency and continence were heterogeneous across studies. The overall pooled patency rate, predominantly defined as freedom from re-intervention rather than objectively confirmed anatomical patency, was 90% (95% confidence interval [CI] 85-93%), with moderate heterogeneity (Q = 11.22). Subgroup analysis by technique yielded patency rates of 87% (95% CI 76-93%) for ventral onlay buccal mucosal graft (BMG) (four studies), 94% (95% CI: 87-97%) for anastomotic urethroplasty (three studies), and 91% (95% CI 83-95%) for dorsal onlay BMG (one study). The pooled UI rate was 5% (95% CI 3-10%), with moderate heterogeneity (Q = 11.38). Sensitivity analysis excluding studies incorporating simple prostatectomy cases (two studies) yielded consistent results. Erectile function data were insufficient for pooled analysis; the two studies reporting Sexual Health Inventory for Men scores documented no significant deterioration. CONCLUSIONS: Urethroplasty for bulbomembranous strictures following BPH surgery achieves high, heterogeneously defined patency-predominantly freedom from re-intervention-with low de novo UI in experienced centres. The heterogeneous, non-comparative evidence precludes technique-specific recommendations; prospective, standardised studies are needed to refine patient selection.
引用
- Scilipoti P, Zorzi F, Folcia A, et al. Urethroplasty for bulbomembranous strictures after benign prostatic hyperplasia surgery: systematic review and meta-analysis. BJU Int. 2026. PMID: 42964010. doi:10.1111/bju.70524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。